Standard
Dual agonistic and antagonistic proberty of non-peptide angiotensin AT1 ligands: Susceptibility to receptor mutations. / Perlman, Signe; Costa-Neto, C.M.; Miyakawa, A.A.; Schambye, Hans T.; Hjorth, Siv A.; Paiva, A.C.; Rivero, R.A.; Greenlee, W.J.; Schwartz, Thue W.
In:
Molecular Pharmaceutics, No. 51, no. 2, 1997, p. 301-311.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Perlman, S, Costa-Neto, CM, Miyakawa, AA, Schambye, HT, Hjorth, SA, Paiva, AC, Rivero, RA, Greenlee, WJ & Schwartz, TW 1997, 'Dual agonistic and antagonistic proberty of non-peptide angiotensin AT1 ligands: Susceptibility to receptor mutations', Molecular Pharmaceutics, no. 51, no. 2, pp. 301-311.
APA
Perlman, S., Costa-Neto, C. M., Miyakawa, A. A., Schambye, H. T., Hjorth, S. A., Paiva, A. C., Rivero, R. A., Greenlee, W. J., & Schwartz, T. W. (1997). Dual agonistic and antagonistic proberty of non-peptide angiotensin AT1 ligands: Susceptibility to receptor mutations. Molecular Pharmaceutics, (51, no. 2), 301-311.
Vancouver
Perlman S, Costa-Neto CM, Miyakawa AA, Schambye HT, Hjorth SA, Paiva AC et al. Dual agonistic and antagonistic proberty of non-peptide angiotensin AT1 ligands: Susceptibility to receptor mutations. Molecular Pharmaceutics. 1997;(51, no. 2):301-311.
Author
Perlman, Signe ; Costa-Neto, C.M. ; Miyakawa, A.A. ; Schambye, Hans T. ; Hjorth, Siv A. ; Paiva, A.C. ; Rivero, R.A. ; Greenlee, W.J. ; Schwartz, Thue W. / Dual agonistic and antagonistic proberty of non-peptide angiotensin AT1 ligands: Susceptibility to receptor mutations. In: Molecular Pharmaceutics. 1997 ; No. 51, no. 2. pp. 301-311.
Bibtex
@article{f70cd23074ca11dbbee902004c4f4f50,
title = "Dual agonistic and antagonistic proberty of non-peptide angiotensin AT1 ligands: Susceptibility to receptor mutations",
abstract = "Farmakologi",
author = "Signe Perlman and C.M. Costa-Neto and A.A. Miyakawa and Schambye, {Hans T.} and Hjorth, {Siv A.} and A.C. Paiva and R.A. Rivero and W.J. Greenlee and Schwartz, {Thue W.}",
year = "1997",
language = "English",
pages = "301--311",
journal = "Molecular Pharmaceutics",
issn = "1543-8384",
publisher = "American Chemical Society",
number = "51, no. 2",
}
RIS
TY - JOUR
T1 - Dual agonistic and antagonistic proberty of non-peptide angiotensin AT1 ligands: Susceptibility to receptor mutations
AU - Perlman, Signe
AU - Costa-Neto, C.M.
AU - Miyakawa, A.A.
AU - Schambye, Hans T.
AU - Hjorth, Siv A.
AU - Paiva, A.C.
AU - Rivero, R.A.
AU - Greenlee, W.J.
AU - Schwartz, Thue W.
PY - 1997
Y1 - 1997
N2 - Farmakologi
AB - Farmakologi
M3 - Journal article
SP - 301
EP - 311
JO - Molecular Pharmaceutics
JF - Molecular Pharmaceutics
SN - 1543-8384
IS - 51, no. 2
ER -
